Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis. - Flex E; Jaiswal M; Pantaleoni F; Martinelli S; Strullu M; Fansa EK; Caye A; De Luca A; Lepri F; Dvorsky R; Pannone L; Paolacci S; et al. (Human molecular genetics, 2014)